1: Safe administration and dosing of EGFR inhibitors in NSCLC - Practical guidance for oncology nurses
Vanessa Beattie speaks to ecancer about the first global lung cancer coalition GLCC patient experience survey. This study investigates lung cancer patient experience in Europe.
Initially, Vanessa talks about the background of the GLCC study. She notes that little comparative European or global data exists on lung cancer patient experience.
The Global Lung Cancer Coalition (GLCC) is a partnership of 40 patient organisations across 29 nations that wanted to understand the experiences of lung cancer patients, identifying common themes and differences between countries.
The GLCC, therefore, used its member networks to run a multi-national online survey of patients.
Vanessa then discusses the common problems that lung cancer patients face throughout their diagnosis and treatment. She talks about why these problems exist and what is the solution for it.
ecancer's filming has been kindly supported by Amgen through the ecancer Global Foundation. ecancer is editorially independent and there is no influence over content.
1: Safe administration and dosing of EGFR inhibitors in NSCLC - Practical guidance for oncology nurses
SIOG 2024: Updates in radiation oncology
SIOG 2024: Updates in medical oncology
Gaza's cancer patients: Navigating the dual struggle of illness and war
Cancer in emergencies: What can we do better to protect the most vulnerable?
Perspectives on advance care planning for advanced cancer in the Philippines
Grand Rounds: Improving quality of patient-centred care
Lung Cancer
Reducing stigma for lung cancer and other smoking-related respiratory diseases